AXQ Capital’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-11,306
Closed -$58.7K 658
2024
Q3
$58.7K Buy
+11,306
New +$58.7K 0.02% 411